
Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc.(IMDX)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
imdx · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$12.00
+109.8% upside
Low
$12.00
Median: $12 · Last Close: $5.72
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $5.68 | ↓ 0.62% |
1-day model range: $5.58–$5.79. Peak: $5.79 (-0.62%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -26.5% |
| 2028 | $4 | -36.2% |
| 2029 | $3 | -40.4% |
| 2030 | $3 | -42.4% |
| 2031 | — | -43.4% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IMDX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-17 | Lake Street | Maintains | Buy→Buy |
| 2025-11-11 | Needham | Maintains | Buy→Buy |
| 2025-08-18 | Needham | Maintains | Buy→Buy |
| 2025-05-21 | Lake Street | Maintains | Buy→Buy |
| 2025-05-13 | Needham | Maintains | Buy→Buy |
| 2025-04-08 | Needham | Maintains | Buy→Buy |
| 2025-03-26 | Stephens & Co. | Maintains | Equal Weight→Equal Weight |
| 2025-03-25 | Needham | Maintains | Buy→Buy |
| 2025-03-25 | Stephens & Co. | Maintains | Equal Weight→Equal Weight |
| 2023-08-23 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
Wall Street analysts have recently issued updated ratings on Insight Molecular Diagnostics Inc. (IMDX) stock. Of the recent 45 rating actions, 1 were upgrades and 6 were downgrades. 11 analysts currently cover IMDX.
分析师推荐趋势
IMDX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$1M
↓ 76.7% YoY
Revenue Next Year
$3M
↑ 545.0% YoY
EPS This Year
$-2.74
EPS Next Year
$-1.15
↓ 58.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast IMDX EPS of $-2.74 for the current fiscal year, based on estimates from 1 analysts. The IMDX revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IMDX 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。IMDX 的共识目标价为 $12.00(+109.8% 上行空间),分析师共识为 Buy。
IMDX 的短期预测(明日)为 $5.68(-0.62%)。 IMDX 对 2027 年的股价预测均值为 $4。 IMDX 对 2030 年的预测区间为 $3–$4。
Insight Molecular Diagnostics Inc. 在 NASDAQ 上市,代码 IMDX。IMDX 在 2027 年的整体展望偏积极,在覆盖分析师中约 64% 对应 Buy 共识。
常见问题
IMDX 预测 · 8 个问题根据 11 位华尔街分析师,IMDX 的 12 个月平均目标价为 $12.00,最高 $12.00、最低 $12.00。若有图表,中位目标价可在上方查看。相对当前价 $5.72,隐含约 +109.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.